BARD1 and cancer: The BARD1 c.2229dupT variant generates a premature termination codon (PTC), affecting the BCRT 2 domain, which is involved in protein-protein interactions and has been linked to DNA repair, recombination, and cell cycle control—mechanisms critical in the development of malignant neoplasms (61, 62).